JBM (Healthcare) Limited (HKG:2161)
Hong Kong · Delayed Price · Currency is HKD 1.920
0.00 (0.00%)
Jul 31, 2026, 3:30 PM HKT
JBM (Healthcare) Financials Overview
Financials in millions HKD. Fiscal year is April - March.
Millions HKD. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 834.63 | 834.63 | 782.29 | 648.42 | 520.32 | 406.14 |
Revenue Growth | 2.66% | 6.69% | 20.65% | 24.62% | 28.12% | 2.26% |
Gross Profit Gross Profit Growth | 465.54 | 465.54 | 413.71 | 338.08 | 205.51 | 161.51 |
Operating Income Operating Income Growth | 264.09 | 264.09 | 233.58 | 162.24 | 70.48 | 41.31 |
Net Income Net Income Growth | 201.09 | 201.09 | 197.26 | 130.46 | 57.09 | 24.62 |
Earnings Per Share EPS Growth | 0.25 | 0.25 | 0.24 | 0.15 | 0.06 | 0.03 |
EPS Growth | 0.01% | 2.27% | 63.11% | 130.48% | 132.92% | -0.95% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Branded Medicines Branded Medicines Growth | 279.97 | 279.97 | 272.23 | 190.11 | 124.04 | 134.33 |
Proprietary Chinese Medicines Proprietary Chinese Medicines Growth | 468.4 | 468.4 | 405.45 | 386.12 | 359.77 | 232.91 |
Health and Wellness Products Health and Wellness Products Growth | 86.26 | 86.26 | 104.61 | 72.19 | 36.52 | 38.9 |
Total Total Growth | 834.63 | 834.63 | 782.29 | 648.42 | 520.32 | 406.14 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 173.98 | 173.98 | 234.56 | 167.21 | 163.48 | 79.24 |
Total Debt Total Debt Growth | 393.72 | 393.72 | 171.75 | 133.41 | 180.1 | 213.09 |
Net Cash (Debt) Net Cash Growth | -219.74 | -219.74 | 62.81 | 33.81 | -16.62 | -133.85 |
Net Cash Growth | - | - | 85.80% | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -0.27 | -0.27 | 0.08 | 0.04 | -0.02 | -0.15 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 162.4 | 162.4 | 226.94 | 191.22 | 145.62 | 60 |
Capital Expenditures CapEx Growth | -33.3 | -33.3 | -21.01 | -10.21 | -8.13 | -7.06 |
Free Cash Flow Free Cash Flow Growth | 129.1 | 129.1 | 205.92 | 181 | 137.48 | 52.94 |
Free Cash Flow Growth | -18.63% | -37.31% | 13.77% | 31.65% | 159.71% | 47.88% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 55.78% | 55.78% | 52.88% | 52.14% | 39.50% | 39.77% |
Operating Margin | 31.64% | 31.64% | 29.86% | 25.02% | 13.54% | 10.17% |
Pretax Margin | 30.21% | 30.21% | 30.89% | 25.43% | 14.78% | 7.57% |
Profit Margin | 24.09% | 24.09% | 25.22% | 20.12% | 10.97% | 6.06% |
FCF Margin | 15.47% | 15.47% | 26.32% | 27.91% | 26.42% | 13.03% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 |
Dividend Per Share Dividend Per Share Growth | 0.171 | 0.171 | 0.170 | 0.075 | 0.030 |
Dividend Per Share Growth | -65.41% | 0.59% | 126.67% | 150.00% | - |
Dividend Yield | 8.91% | 6.43% | 10.20% | 9.12% | 3.40% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 7.80 | 10.81 | 7.39 | 6.05 | 17.28 | 33.03 |
Forward PE | 7.30 | 8.23 | - | - | - | - |
P/FCF Ratio | 12.19 | 16.84 | 7.08 | 4.36 | 7.18 | 15.36 |
PS Ratio | 1.89 | 2.61 | 1.86 | 1.22 | 1.90 | 2.00 |